Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment (CallBack-1)
Evaluation of the Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment Followed by a Return Home
To date, studies have been carried out on emergency department revisits but most are studies carried out in Anglo-Saxon territories. The studies carried out in France, for their part, concern the elderly geriatric population, or populations with specific pathologies such as child psychiatrists or patients with acute heart failure, but not the general adult population. Nevertheless, these studies have shown that knowledge of the risk factors for early readmission of a patient makes it possible to carry out targeted prevention actions in order to reduce this early recourse rate.
However, in a context of increasing emergency flow and increasing tension in the field with limited healthcare resources, returning home and outpatient care are increasingly favored. However, these strategies only make sense if outpatient follow-up is organized when early reconsultation is possible for certain indications that remain to be determined. In this context, it would be interesting to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sabrina Garnier Kepka, MD
- Phone Number: 33 3 69 55 13 35
- Email: Sabrina.GARNIER-KEPKA@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Service d'Accueil des Urgences - CHU de Strasbourg - France
-
Contact:
- Sabrina Garnier Kepka, MD
- Phone Number: 33 3 69 55 13 35
- Email: Sabrina.GARNIER-KEPKA@chru-strasbourg.fr
-
Contact:
- Aline CHENOU, Nurse
- Phone Number: 33 3 69 55 13 35
- Email: aline.chenou@chru-strasbourg.fr
-
Principal Investigator:
- Sabrina Garnier Kepka, MD
-
Principal Investigator:
- Aline CHENOU, Nurse
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Major subject (≥18 years old)
- Subject treated in the emergency room of the NHC or Hautepierre and having consulted the emergency room of one of the two sites 7 days after their first visit for an identical reason for recourse between January 1, 2017 to January 31, 2023.
- Patient who has not expressed his opposition to the reuse of his data for scientific research purposes.
Exclusion Criteria:
- Patient having expressed his opposition to the retrospective reuse of his data
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retrospective description of the most frequent reasons for recourse for which patients benefit from a new emergency consultation for the same reason within 7 days.
Time Frame: up to 7 days
|
The aim of the study is to have information on the reasons for which patients return to the emergency room early after initial treatment.
This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
|
up to 7 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8958
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urgent Care Centers
-
Mathematica Policy Research, Inc.Department of Health and Human Services; University of Massachusetts, BostonCompletedLeadership in Early Care and Education CentersUnited States
-
Abdul Latif Jameel Poverty Action LabCenters for Medicare and Medicaid Services; General Services Administration...WithdrawnDelivery of Health Care | Economics | Fraud | Health Expenditures | Centers for Medicare and Medicaid Services (U.S.) | Prescribing
-
Abdul Latif Jameel Poverty Action LabCenters for Medicare and Medicaid Services; General Services Administration...CompletedDelivery of Health Care | Economics | Fraud | Health Expenditures | Centers for Medicare and Medicaid Services (U.S.)
-
Abdul Latif Jameel Poverty Action LabCenters for Medicare and Medicaid Services; General Services Administration...CompletedDelivery of Health Care | Economics | Fraud | Health Expenditures | Centers for Medicare and Medicaid Services (U.S.)
-
University of NottinghamCompletedFrequent Utilisers of Urgent Medical Care Who Have High Health AnxietyUnited Kingdom
-
University of SheffieldNorthern Health Science Alliance (NHSA)UnknownEmergency and Urgent Care Pathways
-
Yorkshire Ambulance Service NHS TrustUniversity of BradfordNot yet recruitingPoint of Care Testing | Clinical Decision-Making | Community Urgent & Emergency Care | Allied Health Professional
-
AstraZenecaWithdrawnUrgent SurgeryFinland, Italy, Spain, United Kingdom, Belgium, United States, Switzerland, Germany, Hungary, Japan, Mexico, Austria, Australia, Israel, Czechia, Canada, Portugal, Bulgaria, China, Brazil, Taiwan, New Zealand, Slovakia, Poland, Estonia, G... and more
-
The Hospital for Sick ChildrenCompletedSchool Board Health CentersCanada
-
Chang Gung Memorial HospitalRecruiting